Peripheral_JJ
blood_NN
T_NN
cells_NNS
and_CC
monocytes_NNS
and_CC
B_NN
cell_NN
lines_NNS
derived_VBN
from_IN
patients_NNS
with_IN
lupus_NN
express_VBP
estrogen_NN
receptor_NN
transcripts_NNS
similar_JJ
to_TO
those_DT
of_IN
normal_JJ
cells_NNS
._.

OBJECTIVE_NN
:_:
To_TO
identify_VB
and_CC
characterize_VB
estrogen_NN
receptor_NN
-LRB-_-LRB-
ER_NN
-RRB-_-RRB-
transcripts_NNS
expressed_VBD
in_IN
immune_JJ
cells_NNS
of_IN
patients_NNS
with_IN
systemic_JJ
lupus_NN
erythematosus_NN
-LRB-_-LRB-
SLE_NN
-RRB-_-RRB-
and_CC
healthy_JJ
donors_NNS
._.

METHODS_NNS
:_:
Peripheral_JJ
blood_NN
monocytes_NNS
and_CC
T_NN
cells_NNS
were_VBD
prepared_VBN
from_IN
patients_NNS
with_IN
SLE_NN
-LRB-_-LRB-
n_NN
=_JJ
6_CD
-RRB-_-RRB-
and_CC
healthy_JJ
donors_NNS
-LRB-_-LRB-
n_NN
=_JJ
8_CD
-RRB-_-RRB-
._.

T_NN
cells_NNS
were_VBD
separated_VBN
into_IN
CD4_NN
and_CC
CD8_NN
._.

Some_DT
monocytes_NNS
and_CC
T_NN
cells_NNS
were_VBD
stimulated_VBN
with_IN
estradiol_NN
,_,
PMA_NN
,_,
and_CC
ionomycin_NN
._.

Epstein-Barr_JJ
virus-transformed_JJ
B_NN
cell_NN
lines_NNS
-LRB-_-LRB-
n_NN
=_JJ
7_CD
-RRB-_-RRB-
and_CC
B_NN
cell_NN
hybridomas_NNS
-LRB-_-LRB-
n_NN
=_JJ
2_CD
-RRB-_-RRB-
established_VBN
from_IN
patients_NNS
with_IN
SLE_NN
and_CC
a_DT
healthy_JJ
individual_NN
were_VBD
used_VBN
as_IN
a_DT
B_NN
cell_NN
source_NN
._.

These_DT
cells_NNS
were_VBD
examined_VBN
for_IN
ER_NN
mRNA_NN
by_IN
reverse_JJ
transcription_NN
nested_JJ
polymerase_NN
chain_NN
reaction_NN
._.

Amplified_VBN
cDNA_NN
were_VBD
sequenced_VBN
by_IN
standard_JJ
methods_NNS
._.

RESULTS_NNS
:_:
In_IN
all_DT
cells_NNS
tested_VBN
,_,
ER_NN
mRNA_NN
was_VBD
expressed_VBN
without_IN
prior_JJ
in_FW
vitro_FW
stimulation_NN
._.

Partial_JJ
sequences_NNS
from_IN
exons_NNS
1-8_CD
were_VBD
nearly_RB
identical_JJ
to_TO
the_DT
published_VBN
sequence_NN
of_IN
the_DT
human_JJ
ER_NN
mRNA_NN
._.

There_EX
were_VBD
no_DT
notable_JJ
differences_NNS
in_IN
the_DT
ER_NN
transcripts_NNS
between_IN
patients_NNS
and_CC
healthy_JJ
controls_NNS
._.

Variant_JJ
receptor_NN
transcripts_NNS
lacking_VBG
exon_NN
5_CD
or_CC
exon_NN
7_CD
,_,
which_WDT
encodes_VBZ
the_DT
hormone_NN
binding_NN
domain_NN
,_,
were_VBD
identified_VBN
in_IN
the_DT
majority_NN
of_IN
the_DT
cells_NNS
._.

Precise_JJ
deletion_NN
of_IN
the_DT
exons_NNS
suggests_VBZ
that_IN
they_PRP
are_VBP
alternatively_RB
spliced_VBN
transcripts_NNS
._.

Whether_IN
the_DT
detected_JJ
transcripts_NNS
are_VBP
translated_VBN
into_IN
functional_JJ
receptor_NN
proteins_NNS
remains_VBZ
to_TO
be_VB
determined_VBN
._.

In_FW
vitro_FW
stimulation_NN
did_VBD
not_RB
affect_VB
ER_NN
mRNA_NN
expression_NN
._.

The_DT
presence_NN
of_IN
variants_NNS
did_VBD
not_RB
correlate_VB
with_IN
disease_NN
activity_NN
or_CC
medication_NN
._.

CONCLUSION_NN
:_:
Monocytes_NNS
,_,
T_NN
cells_NNS
,_,
and_CC
B_NN
cells_NNS
in_IN
patients_NNS
express_VBP
transcripts_NNS
of_IN
the_DT
normal_JJ
wild_JJ
type_NN
ER_NN
and_CC
the_DT
hormone_NN
binding_NN
domain_NN
variants_NNS
in_FW
vivo_FW
._.

